4//SEC Filing
Schultes Birgit C 4
Accession 0001193125-25-230424
CIK 0001652130other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:13 PM ET
Size
16.2 KB
Accession
0001193125-25-230424
Insider Transaction Report
Form 4
Schultes Birgit C
EVP, Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-10-01$17.38/sh−31$539→ 105,184 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2025, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0002051419
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:13 PM ET
- Size
- 16.2 KB